Portable instrument that integrates irradiation with fluorescence and reflectance spectroscopies during clinical photodynamic therapy of cutaneous disease

We report a portable clinical instrument for delivering photodynamic therapy (PDT) while performing noninvasive spectroscopic monitoring in vivo. Using an off-surface probe, the instrument delivers the treatment beam to a user-defined field on the skin and performs reflectance and fluorescence spectroscopies at two regions within this field. The instrument is being used to monitor photosensitizer fluorescence photobleaching, fluorescent photoproduct kinetics, blood volume, and hemoglobin oxygen saturation during a pilot clinical trial of 5-aminolevulinic acid-PDT treatment of superficial basal cell carcinoma (BCC). Protoporphyrin IX and photoproduct fluorescence excited by the 633nm PDT treatment laser is collected between 655 and 800nm. During a series of brief treatment interruptions at programable time points, white light reflectance spectra between 475 and 800nm are acquired. Fluorescence spectra are corrected for the effects of absorption and scattering, informed by the reflectance measurements, and ...

[1]  R. Rava,et al.  Analytical model for extracting intrinsic fluorescence in turbid media. , 1993, Applied optics.

[2]  C A Morton,et al.  The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments? , 2002, The Journal of dermatological treatment.

[3]  A. Nunn,et al.  Nitroimidazoles and imaging hypoxia , 1995, European Journal of Nuclear Medicine.

[4]  P. Monnier,et al.  Light dosimetry for photodynamic therapy in the esophagus , 1997, Lasers in surgery and medicine.

[5]  W. Star,et al.  Performance of isotropic light dosimetry probes based on scattering bulbs in turbid media. , 2002, Physics in medicine and biology.

[6]  L. Lilge,et al.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.

[7]  J Moan,et al.  5‐Aminolevulinic acid‐based photodynamic therapy , 1997, Cancer.

[8]  Stefan Andersson-Engels,et al.  Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements. , 2005, Applied optics.

[9]  K. Salva.  Photodynamic therapy: unapproved uses, dosages, or indications. , 2002, Clinics in dermatology.

[10]  H. J. van Staveren,et al.  Integrating sphere effect in whole-bladder wall photodynamic therapy: III. Fluence multiplication, optical penetration and light distribution with an eccentric source for human bladder optical properties. , 1996, Physics in medicine and biology.

[11]  H. S. de Bruijn,et al.  Monitoring In Situ Dosimetry and Protoporphyrin IX Fluorescence Photobleaching in the Normal Rat Esophagus During 5-Aminolevulinic Acid Photodynamic Therapy¶ , 2003 .

[12]  S M Evans,et al.  Noninvasive imaging of the distribution in oxygen in tissue in vivo using near-infrared phosphors. , 1996, Biophysical journal.

[13]  Henricus J C M Sterenborg,et al.  In situ light dosimetry during photodynamic therapy of Barrett's esophagus with 5‐aminolevulinic acid , 2002, Lasers in surgery and medicine.

[14]  Thomas H Foster,et al.  Carbogen breathing significantly enhances the penetration of red light in murine tumours in vivo. , 2004, Physics in medicine and biology.

[15]  T. Foster,et al.  Oxygen consumption and diffusion effects in photodynamic therapy. , 1991, Radiation research.

[16]  S. Vinogradov,et al.  Intravascular oxygen distribution in subcutaneous 9L tumors and radiation sensitivity. , 1997, Journal of applied physiology.

[17]  E. Hull,et al.  Porphyrin Bleaching and PDT-induced Spectral Changes are Irradiance Dependent in ALA-sensitized Normal Rat Skin In Vivo¶ , 2001, Photochemistry and photobiology.

[18]  R. Pottier,et al.  5-aminolaevulinic-acid-induced formation of different porphyrins and their photomodifications , 1997, Lasers in Medical Science.

[19]  Stanley B. Brown,et al.  Protoporphyrin IX Fluorescence Photobleaching during ALA‐Mediated Photodynamic Therapy of UVB‐Induced Tumors in Hairless Mouse Skin , 1999, Photochemistry and photobiology.

[20]  Steven L. Jacques,et al.  Simple optical theory for light dosimetry during PDT (Invited Paper) , 1992, Photonics West - Lasers and Applications in Science and Engineering.

[21]  Michele T. Cooper,et al.  Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. , 2000, Cancer research.

[22]  Qian Peng,et al.  An outline of the hundred-year history of PDT. , 2003, Anticancer research.

[23]  M G Nichols,et al.  The Mechanism of Photofrin Photobleaching and Its Consequences for Photodynamic Dosimetry , 1997, Photochemistry and photobiology.